All Stories

  1. HLA and Type 1 diabetes in Iran
  2. Increased P-35, EBI3 Transcripts and Other Treg Markers in Peripheral Blood Mononuclear Cells of Breast Cancer Patients with Different clinical Stages
  3. Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival
  4. Early post-transplant immune monitoring can predict long-term kidney graft survival: Soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies
  5. Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients
  6. Dental caries and salivary sIgA and tobacco smoking
  7. HLA-DRB and HLA-DQA/HLA-DQB allele and haplotype frequencies in Iranian patients with aggressive periodontitis
  8. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: Anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA
  9. Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion
  10. Gastroprotective Effect of NaHS Against Mucosal Lesions Induced by Ischemia–Reperfusion Injury in Rat
  11. Comparison of KIR gene content profiles revealed a difference between northern and southern Persians in the distribution of KIR2DS5 and its linked loci
  12. Microchimerism augmentation in kidney allograft recipients
  13. MP-06.18 Augmentation of Chimerism by Donor Bone Marrow Cells Infusion in Kidney Allograft Recipients
  14. Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material
  15. Quality of tumor lysates used for pulsing dendritic cells is influenced by the method used to harvest adherent tumor cells
  16. 376 AUGMENTATION OF CHIMERISM BY DONOR BONE MARROW CELLS INFUSION IN KIDNEY ALLOGRAFT RECIPIENTS
  17. Serum Levels of Interleukin (IL)-10, IL-17, Transforming Growth Factor (TGF)-β1, and Interferon-γ Cytokines and Expression Levels of IL-10 and TGF-β1 Genes in Renal Allograft Recipients After Donor Bone Marrow Cell Infusion
  18. Sequence-based typing of major histocompatibility complex class I chain-related gene A alleles by use of exons 2-5 information
  19. EFFECTS OF DONOR SPECIFIC BONE MARROW CELLS INFUSION ON LIVING UNRELATED KIDNEY TRANSPLANTATION
  20. The frequency of DRB1*1454 in South German Caucasians
  21. MP-03.08: Effect of Donor Bone Marrow Cells Infusion on Alloimmunization in Kidney Allograft Patients
  22. Th1/Th2 Cytokines and Soluble CD30 Levels in Kidney Allograft Patients With Donor Bone Marrow Cell Infusion
  23. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients
  24. Mannose-binding lectin polymorphisms in common variable immunodeficiency
  25. 591 EFFECT OF DONOR BONE MARROW CELLS INFUSION ON ALLOIMMUNIZATION IN KIDNEY ALLOGRAFT PATIENTS
  26. 596 TH1/TH2 CYTOKINES AND SOLUBLE CD30 LEVELS IN KIDNEY ALLOGRAFT PATIENTS WITH DONOR BONE MARROW CELLS INFUSION
  27. HLA Class II (DRB, DQA1 and DQB1) Allele and Haplotype Frequencies in the Patients with Pemphigus Vulgaris
  28. EFFECT OF DONOR BONE MARROW CELLS INFUSION ON ALLOIMMUNIZATION AND KIDENY ALLOGRAFT OUTCME
  29. Genetic Association of Interleukin-4, Interleukin-10, and Transforming Growth Factor-β Gene Polymorphism With Allograft Function in Renal Transplant Patients
  30. Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice